Cargando…

Integrative brain transcriptome analysis links complement component 4 and HSPA2 to the APOE ε2 protective effect in Alzheimer disease

Mechanisms underlying the protective effect of apolipoprotein E (APOE) ε2 against Alzheimer disease (AD) are not well understood. We analyzed gene expression data derived from autopsied brains donated by 982 individuals including 135 APOE ɛ2/ɛ3 carriers. Complement pathway genes C4A and C4B were amo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panitch, Rebecca, Hu, Junming, Chung, Jaeyoon, Zhu, Congcong, Meng, Gaoyuan, Xia, Weiming, Bennett, David A., Lunetta, Kathryn L., Ikezu, Tsuneya, Au, Rhoda, Stein, Thor D., Farrer, Lindsay A., Jun, Gyungah R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758485/ https://www.ncbi.nlm.nih.gov/pubmed/34480088 http://dx.doi.org/10.1038/s41380-021-01266-z

Ejemplares similares

Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer's disease
por: Jun, Gyungah R., et al.
Publicado: (2022)

Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease
por: Panitch, Rebecca, et al.
Publicado: (2022)

Associations between brain inflammatory profiles and human neuropathology are altered based on apolipoprotein E ε4 genotype
por: Friedberg, Jacob S., et al.
Publicado: (2020)

Identification of an APOE ε4–specific blood‐based molecular pathway for Alzheimer's disease risk
por: Tao, Qiushan, et al.
Publicado: (2023)

Association of APOE Serum Levels and APOE ε2, ε3, and ε4 Alleles with Optic Neuritis
por: Momkute, Liucija, et al.
Publicado: (2022)

Alzheimer’s disease associated AKAP9 I2558M mutation alters posttranslational modification and interactome of tau and cellular functions in CRISPR‐edited human neuronal cells
por: You, Yang, et al.
Publicado: (2022)

Identification of epigenome-wide DNA methylation differences between carriers of APOE ε4 and APOE ε2 alleles
por: Walker, Rosie M., et al.
Publicado: (2021)

Cell-type-specific expression quantitative trait loci associated with Alzheimer disease in blood and brain tissue
por: Patel, Devanshi, et al.
Publicado: (2021)

Corrigendum to “Syk and ye shall find” [EBioMedicine 2 (11) (2015) 190-1591]
por: Wolozin, Benjamin, et al.
Publicado: (2016)

Comparison of methods for multivariate gene-based association tests for complex diseases using common variants
por: Chung, Jaeyoon, et al.
Publicado: (2019)

Tau-tubulin kinase
por: Ikezu, Seiko, et al.
Publicado: (2014)

APOE Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of APOE ε4 on Alzheimer’s Disease Risk in a Multiracial Sample
por: Choi, Kyu Yeong, et al.
Publicado: (2019)

ε2 allele and ε2-involved genotypes (ε2/ε2, ε2/ε3, and ε2/ε4) may confer the association of APOE genetic polymorphism with risks of nephropathy in type 2 diabetes: a meta-analysis
por: Shi, Jikang, et al.
Publicado: (2020)

Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration
por: Su, Wen-Hua, et al.
Publicado: (2017)

The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease
por: Bonham, Luke W., et al.
Publicado: (2016)

Differences in resting-state brain networks and gray matter between APOE ε2 and APOE ε4 carriers in non-dementia elderly
por: Wang, Zhiyuan, et al.
Publicado: (2023)

The impact of increasing levels of blood C-reactive protein on the inflammatory loci SPI1 and CD33 in Alzheimer’s disease
por: Huang, Jinghan, et al.
Publicado: (2022)

HSPA1A, HSPA2, and HSPA8 Are Potential Molecular Biomarkers for Prognosis among HSP70 Family in Alzheimer's Disease
por: Dong, Yeqing, et al.
Publicado: (2022)

Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia
por: Salvadó, Gemma, et al.
Publicado: (2021)

Associations of the APOE ε2 and ε4 alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer’s disease biomarkers
por: Kulminski, Alexander M., et al.
Publicado: (2022)

APOE ε2 is associated with increased tau pathology in primary tauopathy
por: Zhao, Na, et al.
Publicado: (2018)

Functional redundancy of HSPA1, HSPA2 and other HSPA proteins in non-small cell lung carcinoma (NSCLC); an implication for NSCLC treatment
por: Sojka, Damian Robert, et al.
Publicado: (2019)

Upregulation of HSPA1A/HSPA1B/HSPA7 and Downregulation of HSPA9 Were Related to Poor Survival in Colon Cancer
por: Guan, Yufeng, et al.
Publicado: (2021)

Syk and Yea Shall Find
por: Wolozin, Benjamin, et al.
Publicado: (2015)

Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice
por: Pankiewicz, Joanna E, et al.
Publicado: (2014)

Dissecting the Gene Dose-Effects of the APOE ε4 and ε2 Alleles on Hippocampal Volumes in Aging and Alzheimer’s Disease
por: Hostage, Christopher A., et al.
Publicado: (2013)

REDUCED COGNITIVE DECLINE WITH THE APOE ε2/ε2 GENOTYPE IN THE LONG LIFE FAMILY STUDY AND NEW ENGLAND CENTENARIAN STUDY
por: Sweigart, Benjamin, et al.
Publicado: (2019)

Tau Phosphorylation is Impacted by Rare AKAP9 Mutations Associated with Alzheimer Disease in African Americans
por: Ikezu, Tsuneya, et al.
Publicado: (2018)

Crystal Structures of the ATPase Domains of Four Human Hsp70 Isoforms: HSPA1L/Hsp70-hom, HSPA2/Hsp70-2, HSPA6/Hsp70B', and HSPA5/BiP/GRP78
por: Wisniewska, Magdalena, et al.
Publicado: (2010)

Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers
por: Tao, Qiushan, et al.
Publicado: (2018)

The impact of blood MCP-1 levels on Alzheimer’s disease with genetic variation of UNC5C and NAV3 loci
por: Huang, Jinghan, et al.
Publicado: (2023)

Sex and APOE: A memory advantage in male APOE ε4 carriers in midlife
por: Zokaei, Nahid, et al.
Publicado: (2017)

Tau-tubulin kinase 1 and amyloid-β peptide induce phosphorylation of collapsin response mediator protein-2 and enhance neurite degeneration in Alzheimer disease mouse models
por: Ikezu, Seiko, et al.
Publicado: (2020)

Differential expression of HSPA1 and HSPA2 proteins in human tissues; tissue microarray-based immunohistochemical study
por: Scieglinska, Dorota, et al.
Publicado: (2011)

Role of the APOE ε2/ε3/ε4 Polymorphism in the Development of Primary Open-Angle Glaucoma: Evidence from a Comprehensive Meta-Analysis
por: Song, Qinglu, et al.
Publicado: (2013)

Behavioral testing affects the phenotypic expression of APOE ε3 and APOE ε4 in targeted replacement mice and reduces the differences between them
por: Salomon-Zimri, Shiran, et al.
Publicado: (2015)

Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers
por: Sun, Yu, et al.
Publicado: (2019)

Superior short-term memory in APOE ε2 carriers across the age range
por: Zokaei, Nahid, et al.
Publicado: (2021)

Real-Time Imaging and Quantification of Amyloid-β Peptide Aggregates by Novel Quantum-Dot Nanoprobes
por: Tokuraku, Kiyotaka, et al.
Publicado: (2009)

Symptomatic amyloid‐related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab
por: VandeVrede, Lawren, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kj4lpeuht7k9cva3hi666ct694